Type / Class
Equity / Common Stock $0.001 par value per share
Shares outstanding
77.8M
Number of holders
78
Total 13F shares, excl. options
37.6M
Shares change
+2.59M
Total reported value, excl. options
$213M
Value change
+$13.7M
Put/Call ratio
5.37
Number of buys
53
Number of sells
-21
Price
$5.67

Significant Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) as of Q2 2024

87 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share as of Q2 2024.
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37.6M shares of 77.8M outstanding shares and own 48.31% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.91M shares), RA CAPITAL MANAGEMENT, L.P. (4.33M shares), Bain Capital Life Sciences Investors, LLC (4.03M shares), Vestal Point Capital, LP (2.67M shares), Artal Group S.A. (2.5M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.95M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.74M shares), MILLENNIUM MANAGEMENT LLC (1.73M shares), BlackRock Inc. (1.48M shares), and ADAR1 Capital Management, LLC (1.42M shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.